Literature DB >> 20190305

Analysis of wear of retrieved metal-on-metal hip resurfacing implants revised due to pseudotumours.

Y-M Kwon1, S Glyn-Jones, D J Simpson, A Kamali, P McLardy-Smith, H S Gill, D W Murray.   

Abstract

The presence of pseudotumours, which are soft-tissue masses relating to the hip, after metal-on-metal hip resurfacing arthroplasty has been associated with elevated levels of metal ions in serum, suggesting that pseudotumours occur when there is increased wear. We aimed to quantify the wear in vivo of implants revised for pseudotumours (eight) and of a control group of implants (22) revised for other reasons of failure. We found that the implant group with pseudotumours had a significantly higher rate of median linear wear of the femoral component at 8.1 microm/year (2.75 to 25.4) than the 1.79 microm/year (0.82 to 4.15; p = 0.002) of the non-pseudotumour group. For the acetabular component a significantly higher rate of median linear wear of 7.36 microm/year (1.61 to 24.9) was observed in the pseudotumour group compared with 1.28 microm/year (0.81 to 3.33, p = 0.001) in the other group. Wear of the acetabular component in the pseudotumour group always involved the edge of the implant, indicating that edge-loading had occurred. Our findings are the first direct evidence that pseudotumour is associated with increased wear at the metal-on-metal articulation. Furthermore, edge-loading with the loss of fluid-film lubrication may be an important mechanism of generation of wear in patients with a pseudotumour.

Entities:  

Mesh:

Year:  2010        PMID: 20190305     DOI: 10.1302/0301-620X.92B3.23281

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  63 in total

Review 1.  Survival of hard-on-hard bearings in total hip arthroplasty: a systematic review.

Authors:  Michael G Zywiel; Siraj A Sayeed; Aaron J Johnson; Thomas P Schmalzried; Michael A Mont
Journal:  Clin Orthop Relat Res       Date:  2011-06       Impact factor: 4.176

2.  Indications and results of hip resurfacing.

Authors:  D J W McMinn; J Daniel; H Ziaee; C Pradhan
Journal:  Int Orthop       Date:  2010-11-16       Impact factor: 3.075

Review 3.  Surgical management of hip osteoarthritis.

Authors:  Rajiv Gandhi; Anthony V Perruccio; Nizar N Mahomed
Journal:  CMAJ       Date:  2013-10-21       Impact factor: 8.262

Review 4.  New insights into wear and biological effects of metal-on-metal bearings.

Authors:  Isabelle Catelas; Markus A Wimmer
Journal:  J Bone Joint Surg Am       Date:  2011-05       Impact factor: 5.284

5.  Metal-on-metal: history, state of the art (2010).

Authors:  Philippe Triclot
Journal:  Int Orthop       Date:  2011-01-14       Impact factor: 3.075

Review 6.  Polyethylene and metal wear particles: characteristics and biological effects.

Authors:  Isabelle Catelas; Markus A Wimmer; Sandra Utzschneider
Journal:  Semin Immunopathol       Date:  2011-01-26       Impact factor: 9.623

Review 7.  Mediators of the inflammatory response to joint replacement devices.

Authors:  Neil Cobelli; Brian Scharf; Giovanna M Crisi; John Hardin; Laura Santambrogio
Journal:  Nat Rev Rheumatol       Date:  2011-09-06       Impact factor: 20.543

8.  Is there material loss at the backside taper in modular CoCr acetabular liners?

Authors:  Matthias T Agne; Richard J Underwood; Sevi B Kocagoz; Daniel W MacDonald; Judd S Day; Javad Parvizi; Matthew J Kraay; Michael A Mont; Gregg R Klein; Harold E Cates; Steven M Kurtz
Journal:  Clin Orthop Relat Res       Date:  2014-10-16       Impact factor: 4.176

9.  How Useful Is Magnetic Resonance Imaging in Evaluating Adverse Local Tissue Reaction?

Authors:  Douglas E Padgett; Edwin P Su; Timothy M Wright; Alissa J Burge; Hollis G Potter
Journal:  J Arthroplasty       Date:  2020-01-15       Impact factor: 4.757

10.  Histological features of pseudotumor-like tissues from metal-on-metal hips.

Authors:  Pat Campbell; Edward Ebramzadeh; Scott Nelson; Karren Takamura; Koen De Smet; Harlan C Amstutz
Journal:  Clin Orthop Relat Res       Date:  2010-09       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.